烧伤患者的血管活性剂 - 对 ангиотензин-II 的观点
Scott W Mueller1, Nicolas M Tran2, Kevin D Betthauser3
1University of Colorado Health, Department of Pharmacy, Aurora, CO, USA.
概括
本综述检查了严重烧伤休克和败血休克的血管活性剂,强调合成血管酶二 (AT-II) 作为一种潜在的新疗法. 需要进行研究来证实它在烧伤患者中的有效性.
科学领域:
- 关键护理医学 关键护理医学
- 创伤外科 手术 创伤外科
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的烧伤伤害往往导致休克,需要血管活性剂进行血液动力学支持.
- 现有的治疗方法,如甲基荷胺和血管压素有局限性,这促使人们探索新药.
- 氨酸- ангиотензин- алдостерон系统 (RAAS) 在烧伤和败血性休克中经常失调.
研究的目的:
- 审查目前用于急性烧伤休克复苏的血管活性剂.
- 探索合成血管新素-II (AT-II) 在治理烧伤和败血性休克方面的潜在作用.
- 讨论在休克时合成AT-II的生理学理由和现有数据.
主要方法:
- 关于烧伤和败血症休克中血管活性剂的现有文献的叙述性综述.
- 对烧伤病理生理学的分析及其对RAAS的影响.
- 在分布性休克群体中对合成AT-II的现有数据的评估.
主要成果:
- 甲基荷胺和血管压素是标准的,但有缺点.
- 合成AT-II在其他分布性休克病例中改善血液动力学方面表现有前途.
- 目前关于合成AT-II的数据有限,专门用于急性烧伤休克和烧伤患者的败血休克.
结论:
- 合成AT-II为严重烧伤和败血症休克提供了潜在的治疗选择.
- 进一步的研究对于确定合成AT-II在烧伤群体中的安全性和有效性至关重要.
- 了解烧伤休克RAAS失调是优化治疗策略的关键.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
581
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
581
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
477
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
477
Antihypertensive Drugs: Direct Renin Inhibitors
490
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
490
Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
Burn Injuries
2.4K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
2.4K


